'Mind the gaps': the accessibility and implementation of an effective depression relapse prevention programme in UK NHS services: learning from mindfulness-based cognitive therapy through a mixed-methods study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
08 09 2019
Historique:
entrez: 11 9 2019
pubmed: 11 9 2019
medline: 2 10 2020
Statut: epublish

Résumé

Mindfulness-based cognitive therapy (MBCT) is an evidence-based approach for people at risk of depressive relapse to support their long-term recovery. However, despite its inclusion in guidelines, there is an 'implementation cliff'. The study objective was to develop a better explanation of what facilitates MBCT implementation. UK primary and secondary care mental health services. A national two-phase, multi-method qualitative study was conducted, which was conceptually underpinned by the Promoting Action on Research Implementation in Health Services framework. Phase I involved interviews with stakeholders from 40 service providers about current provision of MBCT. Phase II involved 10 purposively sampled case studies to obtain a more detailed understanding of MBCT implementation. Data were analysed using adapted framework analysis, refined through stakeholder consultation. Access to MBCT is variable across the UK services. Where available, services have adapted MBCT to fit their context by integrating it into their care pathways. Evidence was often important to implementation but took different forms: the NICE depression guideline, audits, evaluations, first person accounts, experiential taster sessions and pilots. These were used to build a platform from which to develop MBCT services. The most important aspect of facilitation was the central role of the MBCT implementers. These were generally self-designated individuals who 'championed' grass-roots implementation. Our explanatory framework mapped out a prototypical implementation journey, often over many years with a balance of bottom-up and top-down factors influencing the fit of MBCT into service pathways. 'Pivot points' in the implementation journey provided windows of either challenge or opportunity. This is one of the largest systematic studies of the implementation of a psychological therapy. While access to MBCT across the UK is improving, it remains patchy. The resultant explanatory framework about MBCT implementation provides a heuristic that informed an implementation resource.

Identifiants

pubmed: 31501097
pii: bmjopen-2018-026244
doi: 10.1136/bmjopen-2018-026244
pmc: PMC6738673
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e026244

Subventions

Organisme : Department of Health
ID : 12/64/187
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104908/Z/14/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT104908MA
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JR-M was a commissioned work stream board member of the HS&DR Programme when this work was funded, and subsequently was appointed as NIHR HS&DR Programme Director. RSC receives royalties for MBCT Distinctive Features, Routledge 2017. She is a trustee of the Mindfulness Network, a charity offering CPD services to mindfulness-based teachers. She directs the Centre for Mindfulness Research and Practice at Bangor University which delivers professional training for mindfulness-based teachers. WK is the Director of the Oxford Mindfulness Centre, a research, training and education centre that is a collaboration between the University of Oxford and the not-for-profit charity, the Oxford Mindfulness Foundation. He donates all speaking or consultancy fees in full to the Oxford Mindfulness Foundation.

Références

Implement Sci. 2009 Nov 30;4:78
pubmed: 19948064
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Implement Sci. 2010 Oct 25;5:82
pubmed: 20973988
Int Rev Psychiatry. 2011 Aug;23(4):318-27
pubmed: 22026487
Lancet. 2007 Sep 8;370(9590):851-8
pubmed: 17826170
BMC Health Serv Res. 2015 Feb 14;15:62
pubmed: 25890333
J Consult Clin Psychol. 2016 Aug;84(8):726-37
pubmed: 27100125
Milbank Q. 2004;82(4):581-629
pubmed: 15595944
Mindfulness (N Y). 2013;4:246-254
pubmed: 23956806
Implement Sci. 2016 Mar 10;11:33
pubmed: 27013464
Behav Ther. 2018 Jan;49(1):124-147
pubmed: 29405918
J Nurs Care Qual. 2004 Oct-Dec;19(4):297-304
pubmed: 15535533
Clin Psychol Rev. 2011 Nov;31(7):1117-25
pubmed: 21820991
Behav Res Ther. 2017 Aug;95:29-41
pubmed: 28527330
Implement Sci. 2011 Aug 30;6:99
pubmed: 21878092
Implement Sci. 2016 Feb 09;11:17
pubmed: 26860631
Mindfulness (N Y). 2020;11(2):279-290
pubmed: 32064009
Mindfulness (N Y). 2019 Jun 4;10(2):376-389
pubmed: 31186817
Nature. 2011 Jul 06;475(7354):27-30
pubmed: 21734685
BMJ. 2006 Apr 29;332(7548):1030-2
pubmed: 16644834
Implement Sci. 2008 Jan 07;3:1
pubmed: 18179688
Implement Sci. 2014 May 24;9:62
pubmed: 24884603
BMJ. 2012 Nov 09;345:e7194
pubmed: 23144206
Behav Cogn Psychother. 2009 Jul;37(4):413-30
pubmed: 19508744
Annu Rev Clin Psychol. 2010;6:181-212
pubmed: 20192789
BMJ Open. 2019 Sep 8;9(9):e026244
pubmed: 31501097
Psychol Bull. 2007 Jan;133(1):122-48
pubmed: 17201573

Auteurs

Jo Rycroft-Malone (J)

School of Health Sciences, Bangor University, Bangor, UK.

Felix Gradinger (F)

Institute of Health Research, University of Exeter, Exeter, UK.

Heledd Owen Griffiths (H)

School of Health Sciences, Bangor University, Bangor, UK.

Rob Anderson (R)

Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.

Rebecca Susan Crane (RS)

School of Psychology, Bangor University, Bangor, UK.

Andy Gibson (A)

Health and Social Sciences, University of the West of England, Bristol, UK.

Stewart W Mercer (SW)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Willem Kuyken (W)

Psychiatry, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH